{
    "Symbol": "MEDP",
    "AssetType": "Common Stock",
    "Name": "Medpace Holdings Inc",
    "Description": "Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company is headquartered in Cincinnati, Ohio.",
    "CIK": "1668397",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "TRADE & SERVICES",
    "Industry": "SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH",
    "Address": "5375 MEDPACE WAY, CINCINNATI, OH, US",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-06-30",
    "MarketCapitalization": "11940653000",
    "EBITDA": "409524000",
    "PERatio": "36.23",
    "PEGRatio": "2.684",
    "BookValue": "24.69",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "10.63",
    "RevenuePerShareTTM": "65.92",
    "ProfitMargin": "0.167",
    "OperatingMarginTTM": "0.199",
    "ReturnOnAssetsTTM": "0.143",
    "ReturnOnEquityTTM": "0.589",
    "RevenueTTM": "2030048000",
    "GrossProfitTTM": "925109000",
    "DilutedEPSTTM": "10.63",
    "QuarterlyEarningsGrowthYOY": "0.425",
    "QuarterlyRevenueGrowthYOY": "0.146",
    "AnalystTargetPrice": "406.91",
    "AnalystRatingStrongBuy": "4",
    "AnalystRatingBuy": "3",
    "AnalystRatingHold": "2",
    "AnalystRatingSell": "0",
    "AnalystRatingStrongSell": "0",
    "TrailingPE": "36.23",
    "ForwardPE": "36.9",
    "PriceToSalesRatioTTM": "6.49",
    "PriceToBookRatio": "21.9",
    "EVToRevenue": "6.43",
    "EVToEBITDA": "33.42",
    "Beta": "1.356",
    "52WeekHigh": "459.77",
    "52WeekLow": "227.21",
    "50DayMovingAverage": "403.06",
    "200DayMovingAverage": "351.77",
    "SharesOutstanding": "31001800",
    "DividendDate": "None",
    "ExDividendDate": "None"
}